Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients: A Multicenter, Openlabel, Randomized, Phase III Trial

NCT06437977 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT06437977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06437977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients: A Multicenter, Openlabel, Randomized, Phase III Trial
Lead sponsor
Shanghai Chest Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
September 12, 2024
Completion date
June 30, 2029
Enrollment
478 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii-iii non-small cell lung cancer